These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 14657181
1. Angiotensin II blocks nicotine-mediated neuroprotection against beta-amyloid (1-42) via activation of the tyrosine phosphatase SHP-1. Shaw S, Bencherif M, Marrero MB. J Neurosci; 2003 Dec 03; 23(35):11224-8. PubMed ID: 14657181 [Abstract] [Full Text] [Related]
2. The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase. Marrero MB, Papke RL, Bhatti BS, Shaw S, Bencherif M. J Pharmacol Exp Ther; 2004 Apr 03; 309(1):16-27. PubMed ID: 14722323 [Abstract] [Full Text] [Related]
3. Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid. Shaw S, Bencherif M, Marrero MB. J Biol Chem; 2002 Nov 22; 277(47):44920-4. PubMed ID: 12244045 [Abstract] [Full Text] [Related]
4. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2. Marrero MB, Venema VJ, Ju H, Eaton DC, Venema RC. Am J Physiol; 1998 Nov 22; 275(5):C1216-23. PubMed ID: 9814969 [Abstract] [Full Text] [Related]
5. Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB. Marrero MB, Bencherif M. Brain Res; 2009 Feb 23; 1256():1-7. PubMed ID: 19063868 [Abstract] [Full Text] [Related]
6. Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells. Cui TX, Nakagami H, Nahmias C, Shiuchi T, Takeda-Matsubara Y, Li JM, Wu L, Iwai M, Horiuchi M. Mol Endocrinol; 2002 Sep 23; 16(9):2113-23. PubMed ID: 12198247 [Abstract] [Full Text] [Related]
7. Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell. Cui T, Nakagami H, Iwai M, Takeda Y, Shiuchi T, Daviet L, Nahmias C, Horiuchi M. Cardiovasc Res; 2001 Mar 23; 49(4):863-71. PubMed ID: 11230986 [Abstract] [Full Text] [Related]
8. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, Marrero MB. Kidney Int; 2002 May 23; 61(5):1605-16. PubMed ID: 11967010 [Abstract] [Full Text] [Related]
9. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2. Tang H, Zhao ZJ, Landon EJ, Inagami T. J Biol Chem; 2000 Mar 24; 275(12):8389-96. PubMed ID: 10722671 [Abstract] [Full Text] [Related]
10. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Bedecs K, Elbaz N, Sutren M, Masson M, Susini C, Strosberg AD, Nahmias C. Biochem J; 1997 Jul 15; 325 ( Pt 2)(Pt 2):449-54. PubMed ID: 9230127 [Abstract] [Full Text] [Related]
11. High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway. Shaw S, Wang X, Redd H, Alexander GD, Isales CM, Marrero MB. J Biol Chem; 2003 Aug 15; 278(33):30634-41. PubMed ID: 12777386 [Abstract] [Full Text] [Related]
12. Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells. Doan T, Farmer P, Cooney T, Ali MS. Cell Signal; 2004 Mar 15; 16(3):301-11. PubMed ID: 14687660 [Abstract] [Full Text] [Related]
13. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor. Matsubara H, Shibasaki Y, Okigaki M, Mori Y, Masaki H, Kosaki A, Tsutsumi Y, Uchiyama Y, Fujiyama S, Nose A, Iba O, Tateishi E, Hasegawa T, Horiuchi M, Nahmias C, Iwasaka T. Biochem Biophys Res Commun; 2001 Apr 20; 282(5):1085-91. PubMed ID: 11302725 [Abstract] [Full Text] [Related]
14. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor. Godeny MD, Sayyah J, VonDerLinden D, Johns M, Ostrov DA, Caldwell-Busby J, Sayeski PP. Cell Signal; 2007 Mar 20; 19(3):600-9. PubMed ID: 17027227 [Abstract] [Full Text] [Related]
15. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli. Banes AK, Shaw S, Jenkins J, Redd H, Amiri F, Pollock DM, Marrero MB. Am J Physiol Renal Physiol; 2004 Apr 20; 286(4):F653-9. PubMed ID: 14678947 [Abstract] [Full Text] [Related]
16. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription. Berchtold S, Volarevic S, Moriggl R, Mercep M, Groner B. Mol Endocrinol; 1998 Apr 20; 12(4):556-67. PubMed ID: 9544991 [Abstract] [Full Text] [Related]
17. Gbeta gamma -independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1. Feng YH, Sun Y, Douglas JG. Proc Natl Acad Sci U S A; 2002 Sep 17; 99(19):12049-54. PubMed ID: 12221292 [Abstract] [Full Text] [Related]
18. Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis. Lehtonen JY, Daviet L, Nahmias C, Horiuchi M, Dzau VJ. Mol Endocrinol; 1999 Jul 17; 13(7):1051-60. PubMed ID: 10406457 [Abstract] [Full Text] [Related]
19. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells. Wu DW, Stark KC, Dunnington D, Dillon SB, Yi T, Jones C, Pelus LM. Blood Cells Mol Dis; 2000 Feb 17; 26(1):15-24. PubMed ID: 10772872 [Abstract] [Full Text] [Related]
20. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. Bousquet C, Susini C, Melmed S. J Clin Invest; 1999 Nov 17; 104(9):1277-85. PubMed ID: 10545526 [Abstract] [Full Text] [Related] Page: [Next] [New Search]